Author (Year) | EA | Factors | |
---|---|---|---|
Responder → Non-responder | Non-responder → Responder | ||
Kim (2014) | LF | Inhibiting AMPK activity in the hypothalamus | Â |
Fais (2012) | LF | Â | Inhibitor of norepinephrine and serotonin uptake at spinal terminals of descending pain inhibitory pathways (amitriptyline, i.p. or i.t) |
Kim (2007) | LF | Â | CCK-AR KO |
Sekido (2003) | LF | Naloxone (opioid receptor antagonist, i.p.) | Â |
Takeshige (1993) | LF | -Hypophysectomy -Antiserum of β-endorphin (i.c.v.) | Inhibitor of the degrading enzymes of met-enkephalin (DPA, i.p.) |
Takeshige (1992) | LF | Hypophysectomy | - Morphine (i.p.) - Morphine (into post. Arcuate nucleus) - β-endorphin (into post. Arcuate nucleus) |
Han (1985) | IF | Â | CCK-8 AS (i.c.v. or i.t.) |
Tian (1998) | HF | OFQ-Ab (i.t.) | OFQ-Ab (i.c.v.) |
Tang (1997) | HF | Â | Antisense CCK (i.c.v.) |